Our long-standing, flagship SCREEN-WELL® Compound Library portfolio offers an easy, ready-to-use method to streamline compound screening. We offer a unique collection of Epigenetic Pathway targeting compounds, as well as focused libraries for kinase inhibitors, protease inhibitors, and more.
The SCREEN-WELL® Epigenetics library is a curated set of compounds with defined activity against epigenetic modulating enzymes. It is a convenient tool for use with HDAC & Sirtuin drug discovery kits:
Contains 43 compounds with defined activity against lysine-modifying enzymes and DNA methylation inhibitors
Available in 100uL and 500uL formats, dissolved in DMSO
Includes a variety of structurally and mechanistically different compound classes targeting HDACs, SIRTs, HATs, HMTs, DNAMTs, and Lysine demethylases